NCT06741332 Accelerating Referral for Thrombectomy in Acute Stroke Patients Using an Artificial Intelligence-based Software
| NCT ID | NCT06741332 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-01-27 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-01-27 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if an AI-based imaging software, Methinks Stroke Suite, can reduce the time to transfer stroke patients who need thrombectomy from local stroke centers to specialized centers. The study focuses on acute stroke patients who are initially evaluated at local stroke centers that cannot perform endovascular therapy (EVT). The main questions it aims to answer are: * Does Methinks Stroke Suite reduce the time it takes to decide if a patient needs to be transferred for thrombectomy? * How accurate is the AI software in identifying patients who are candidates for EVT? Researchers will compare the AI-based workflow to a historical cohort to see if the Methinks Stroke Suite improves transfer decisions and treatment times. Participants will: * Undergo a CT scan at the local stroke center, which will be analyzed by Methinks Stroke Suite. * Be transferred to a thrombectomy-capable center if the AI + clinical judgment identifies them as potential EVT candidates. * Be followed for 90 days after their stroke to assess recovery outcomes.
Eligibility Criteria
Inclusion Criteria: 1. Suspected acute stroke patients 2. \>18 years with no upper age limit 3. Included \< 24 h since last seen well 4. Non-contrast CT is available at the local stroke center 5. Image has been processed by Methinks Stroke Suite 6. Informed consent obtained from a patient or his or her legally designated representative (if locally required). Exclusion Criteria: 1. Patients in a coma (NIHSS item of consciousness \>1) 2. Patients with unstable clinical status who require emergent life support care 3. Subject imaging does not meet Image Acquisition and DICOM Tag Requirements
Frequently Asked Questions
Who can join the NCT06741332 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06741332 currently recruiting?
Yes, NCT06741332 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hospital Universitari Vall d'Hebron Research Institute to inquire about joining.
Where is the NCT06741332 trial being conducted?
This trial is being conducted at Granollers, Spain, Barcelona, Spain.
Who is sponsoring the NCT06741332 clinical trial?
NCT06741332 is sponsored by Hospital Universitari Vall d'Hebron Research Institute. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.